{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,14]],"date-time":"2026-01-14T17:33:26Z","timestamp":1768412006319,"version":"3.49.0"},"reference-count":34,"publisher":"Spandidos Publications","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2015,5]]},"DOI":"10.3892\/mco.2015.515","type":"journal-article","created":{"date-parts":[[2015,2,25]],"date-time":"2015-02-25T09:27:02Z","timestamp":1424856422000},"page":"464-470","source":"Crossref","is-referenced-by-count":8,"title":["Expression of insulin-like growth factor I receptor as a biomarker for predicting prognosis in biliary tract cancer patients"],"prefix":"10.3892","volume":"3","author":[{"given":"HIDEO","family":"SUZUKI","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"JUAN C.","family":"ROA","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"TORU","family":"KAWAMOTO","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"KAZUNORI","family":"ISHIGE","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"IGNACIO I.","family":"WISTUBA","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"DONGHUI","family":"LI","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"MELANIE B.","family":"THOMAS","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"JUNICHI","family":"SHODA","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"2249","published-online":{"date-parts":[[2015,2,25]]},"reference":[{"key":"key20180107145030_b1-mco-0-0-515","doi-asserted-by":"crossref","first-page":"1689","DOI":"10.1002\/cncr.11699","article-title":"Patterns of initial disease recurrence after resection of gallbladder carcinoma and hilar cholangiocarcinoma: implications for adjuvant therapeutic strategies","volume":"98","author":"Jarnagin","year":"2003","journal-title":"Cancer"},{"key":"key20180107145030_b2-mco-0-0-515","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1016\/j.jhep.2003.11.030","article-title":"Rising incidence of intrahepatic cholangiocarcinoma in the United States: a true increase?","volume":"40","author":"Shaib","year":"2004","journal-title":"J Hepatol"},{"key":"key20180107145030_b3-mco-0-0-515","doi-asserted-by":"crossref","first-page":"10","DOI":"10.3322\/canjclin.55.1.10","article-title":"Cancer statistics 2005","volume":"55","author":"Jemal","year":"2005","journal-title":"CA Cancer J Clin"},{"key":"key20180107145030_b4-mco-0-0-515","doi-asserted-by":"crossref","first-page":"1591","DOI":"10.1002\/ijc.21683","article-title":"Gallbladder cancer worldwide: geographical distribution and risk factors","volume":"118","author":"Randi","year":"2006","journal-title":"Int J Cancer"},{"key":"key20180107145030_b5-mco-0-0-515","first-page":"1540","article-title":"Gallbladder cancer in a high risk area: morphological features and spread patterns","volume":"46","author":"Roa","year":"1999","journal-title":"Hepatogastroenterology"},{"key":"key20180107145030_b6-mco-0-0-515","doi-asserted-by":"crossref","first-page":"1195","DOI":"10.4067\/S0034-98872001001000014","article-title":"Cancer mortality in Chile: epidemiological considerations","volume":"129","author":"Medina","year":"2001","journal-title":"Rev Med Chil"},{"key":"key20180107145030_b7-mco-0-0-515","doi-asserted-by":"crossref","first-page":"1258","DOI":"10.1016\/0016-5085(85)90641-9","article-title":"Association of gallbladder carcinoma and anomalous pancreaticobiliary ductal union","volume":"89","author":"Kimura","year":"1985","journal-title":"Gastroenterology"},{"key":"key20180107145030_b8-mco-0-0-515","first-page":"221","article-title":"HER receptor family: novel candidate for targeted therapy for gallbladder and extrahepatic bile duct cancer","volume":"1","author":"Kawamoto","year":"2007","journal-title":"Gastrointest Cancer Res"},{"key":"key20180107145030_b9-mco-0-0-515","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1093\/annonc\/10.suppl_4.S136","article-title":"Histological and genetic changes in malignant transformation of gallbladder adenoma","volume":"10","author":"Watanabe","year":"1999","journal-title":"Ann Oncol"},{"key":"key20180107145030_b10-mco-0-0-515","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1016\/S1470-2045(02)00731-3","article-title":"Insulin-like growth factors and cancer","volume":"3","author":"Furstenberger","year":"2002","journal-title":"Lancet Oncol"},{"key":"key20180107145030_b11-mco-0-0-515","first-page":"3736","article-title":"Insulin-like growth factor-I receptors are overexpressed and predict a low risk in human breast cancer","volume":"53","author":"Papa","year":"1993","journal-title":"Cancer Res"},{"key":"key20180107145030_b12-mco-0-0-515","doi-asserted-by":"crossref","first-page":"3022","DOI":"10.1158\/1078-0432.CCR-07-1898","article-title":"Impact of insulin-like growth factor type 1 receptor, epidermal growth factor receptor, and HER2 expressions on outcomes of patients with gastric cancer","volume":"14","author":"Matsubara","year":"2008","journal-title":"Clin Cancer Res"},{"key":"key20180107145030_b13-mco-0-0-515","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/S0304-3835(03)00159-9","article-title":"The insulin-like growth factor system and cancer","volume":"195","author":"LeRoith","year":"2003","journal-title":"Cancer Lett"},{"key":"key20180107145030_b14-mco-0-0-515","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1023\/B:HIJO.0000032356.98363.a2","article-title":"IGF-I receptor, cell-cell adhesion, tumor development and progression","volume":"35","author":"Mauro","year":"2004","journal-title":"J Mol Histol"},{"key":"key20180107145030_b15-mco-0-0-515","doi-asserted-by":"crossref","first-page":"1377","DOI":"10.1097\/01.LAB.0000032411.41603.C2","article-title":"Impact of insulin-like growth factor receptor-I function on angiogenesis, growth, and metastasis of colon cancer","volume":"82","author":"Reinmuth","year":"2002","journal-title":"Lab Invest"},{"key":"key20180107145030_b16-mco-0-0-515","doi-asserted-by":"crossref","first-page":"947","DOI":"10.1093\/carcin\/bgl247","article-title":"Insulin-like growth factor-I receptor as a marker for prognosis and a therapeutic target in human esophageal squamous cell carcinoma","volume":"28","author":"Imsumran","year":"2007","journal-title":"Carcinogenesis"},{"key":"key20180107145030_b17-mco-0-0-515","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1136\/jcp.2005.028480","article-title":"Expression of IGF-I, IGF-II, and IGF-IR in gallbladder carcinoma. A systematic analysis including primary and corresponding metastatic tumors","volume":"59","author":"Kornprat","year":"2006","journal-title":"J Clin Pathol"},{"key":"key20180107145030_b18-mco-0-0-515","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1111\/j.1349-7006.2011.02138.x","article-title":"Insulin-like growth factor receptor expression is associated with aggressive phenotypes and has therapeutic activity in biliary tract cancers","volume":"103","author":"Ohashi","year":"2012","journal-title":"Cancer Sci"},{"key":"key20180107145030_b19-mco-0-0-515","doi-asserted-by":"crossref","first-page":"2516","DOI":"10.1200\/JCO.2008.19.9331","article-title":"Phase II study of the anti-insulin-like growth factor type 1 receptor antibody CP-751,871 in combination with paclitaxel and carboplatin in previously untreated, locally advanced, or metastatic non-small-cell lung cancer","volume":"27","author":"Karp","year":"2009","journal-title":"J Clin Oncol"},{"key":"key20180107145030_b20-mco-0-0-515","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1016\/j.phrs.2004.03.007","article-title":"mTOR: a protein kinase switching between life and death","volume":"50","author":"Asnaghi","year":"2004","journal-title":"Pharmacol Res"},{"key":"key20180107145030_b21-mco-0-0-515","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/j.semcdb.2003.12.023","article-title":"PI3-kinase and TOR: PIKTORing cell growth","volume":"15","author":"Richardson","year":"2004","journal-title":"Semin Cell Dev Biol"},{"key":"key20180107145030_b22-mco-0-0-515","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1016\/j.cell.2006.01.016","article-title":"TOR signaling in growth and metabolism","volume":"124","author":"Wullschleger","year":"2006","journal-title":"Cell"},{"key":"key20180107145030_b23-mco-0-0-515","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1078\/0344-0338-00016","article-title":"Expression and clinical significance of the erbB family in intrahepatic cholangiocellular carcinoma","volume":"197","author":"Ito","year":"2001","journal-title":"Pathol Res Pract"},{"key":"key20180107145030_b24-mco-0-0-515","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/0046-8177(93)90060-T","article-title":"Expression of oncogene products and growth factors in early gallbladder cancer, advanced gallbladder cancer, and chronic cholecystitis","volume":"24","author":"Yukawa","year":"1993","journal-title":"Hum Pathol"},{"key":"key20180107145030_b25-mco-0-0-515","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1007\/s005340050177","article-title":"Comparative clinicopathological study of resected intrahepatic cholangiocarcinoma in northeast Thailand and Japan","volume":"7","author":"Suzuki","year":"2000","journal-title":"J Hepatobiliary Pancreat Surg"},{"key":"key20180107145030_b26-mco-0-0-515","doi-asserted-by":"crossref","first-page":"780","DOI":"10.1016\/S0168-8278(02)00057-0","article-title":"Gene amplification and mRNA and protein overexpression of c-erbB-2 (HER-2\/neu) in human intrahepatic cholangiocarcinoma as detected by fluorescence in situ hybridization, in situ hybridization, and immunohistochemistry","volume":"36","author":"Ukita","year":"2002","journal-title":"J Hepatol"},{"key":"key20180107145030_b27-mco-0-0-515","doi-asserted-by":"crossref","first-page":"552","DOI":"10.5858\/arpa.2012-0032-OA","article-title":"Immunohistochemical expression of phospho-mTOR is associated with poor prognosis in patients with gallbladder adenocarcinoma","volume":"137","author":"Leal","year":"2013","journal-title":"Arch Pathol Lab Med"},{"key":"key20180107145030_b28-mco-0-0-515","first-page":"1373","article-title":"AKT\/mTOR substrate P70S6K is frequently phosphorylated in gallbladder cancer tissue and cell lines","volume":"6","author":"Leal","year":"2013","journal-title":"Onco Targets Ther"},{"key":"key20180107145030_b29-mco-0-0-515","doi-asserted-by":"crossref","first-page":"3794","DOI":"10.1158\/0008-5472.CAN-06-3214","article-title":"Therapeutic effect of rapamycin on gallbladder cancer in a transgenic mouse model","volume":"67","author":"Wu","year":"2007","journal-title":"Cancer Res"},{"key":"key20180107145030_b30-mco-0-0-515","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1042\/bj3510289","article-title":"Meaningful relationships: the regulation of the Ras\/Raf\/MEK\/ERK pathway by protein interactions","volume":"351","author":"Kolch","year":"2000","journal-title":"Biochem J"},{"key":"key20180107145030_b31-mco-0-0-515","first-page":"2217","article-title":"v-raf suppresses apoptosis and promotes growth of interleukin-3-dependent myeloid cells","volume":"9","author":"Cleveland","year":"1994","journal-title":"Oncogene"},{"key":"key20180107145030_b32-mco-0-0-515","doi-asserted-by":"crossref","first-page":"5308","DOI":"10.1128\/MCB.19.8.5308","article-title":"B-Raf inhibits programmed cell death downstream of cytochrome c release from mitochondria by activating the MEK\/Erk pathway","volume":"19","author":"Erhardt","year":"1999","journal-title":"Mol Cell Biol"},{"key":"key20180107145030_b33-mco-0-0-515","doi-asserted-by":"crossref","first-page":"1753","DOI":"10.1054\/bjoc.2001.2139","article-title":"Association of c-Raf expression with survival and its targeting with antisense oligonucleotides in ovarian cancer","volume":"85","author":"McPhillips","year":"2001","journal-title":"Br J Cancer"},{"key":"key20180107145030_b34-mco-0-0-515","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1016\/0964-1955(95)00045-3","article-title":"Differential c-myc, c-jun, c-raf and p53 expression in squamous cell carcinoma of the head and neck: implication in drug and radioresistance","volume":"31B","author":"Riva","year":"1995","journal-title":"Eur J Cancer B Oral Oncol"}],"container-title":["Molecular and Clinical Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/spandidos-publications.com\/10.3892\/mco.2015.515\/download","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2018,1,7]],"date-time":"2018-01-07T09:50:56Z","timestamp":1515318656000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.spandidos-publications.com\/10.3892\/mco.2015.515"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,2,25]]},"references-count":34,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2015,2,25]]},"published-print":{"date-parts":[[2015,5]]}},"alternative-id":["10.3892\/mco.2015.515"],"URL":"https:\/\/doi.org\/10.3892\/mco.2015.515","relation":{},"ISSN":["2049-9450","2049-9469"],"issn-type":[{"value":"2049-9450","type":"print"},{"value":"2049-9469","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,2,25]]}}}